Hanchuan Zupa Granules attenuate host inflammatory and redox dysregulation in a pretreatment model of Pseudomonas aeruginosa-triggered acute lung injury.
ETHNOPHARMACOLOGICAL RELEVANCE Acute infectious lung injury involves excessive innate inflammation, oxidative stress, and epithelial barrier damage. Hanchuan Zupa Granules (HCZP), a Uyghur patent medicine, are traditionally used for cold-type Nazla characterized by cough, dyspnea, and viscous sputum. AIM OF THE STUDY...